QPBE
LXRX icon

Quintet Private Bank (Europe)’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quintet Private Bank (Europe)’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,928
Closed -$1.82K – 217
2025
Q2 		$1.82K Hold
1,928
– – ﹤0.01% 212
2025
Q1 		$888 Hold
1,928
– – ﹤0.01% 201
2024
Q4 		$1.42K Hold
1,928
– – ﹤0.01% 212
2024
Q3 		$3.03K Buy
1,928
+246
+15% +$438 ﹤0.01% 189
2024
Q2 		$3.24K Sell
1,682
-67
-4% -$120 ﹤0.01% 195
2024
Q1 		$4.6K Sell
1,749
-179
-9% -$385 ﹤0.01% 213
2023
Q4 		$2.95K Hold
1,928
– – ﹤0.01% 189
2023
Q3 		$2.1K Buy
1,928
+33
+2% +$58 ﹤0.01% 223
2023
Q2 		$4.4K Sell
1,895
-35
-2% -$93 ﹤0.01% 235
2023
Q1 		$4.69K Buy
+1,930
New +$4.42K ﹤0.01% 263
2022
Q2 		$4.4K Buy
+1,895
New +$3.62K ﹤0.01% 235

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quintet Private Bank (Europe)'s LXRX Position: Q3 2025 in Review

Quintet Private Bank (Europe) sold out of Lexicon Pharmaceuticals (LXRX) in Q3 2025, closing a stake of 1,928 shares — an estimated $1.82K sold.

Quintet Private Bank (Europe) first reported a position in LXRX in Q2 2022 and held it in 11 quarters. The position peaked at $4.69K in Q1 2023. 123 funds tracked by Wall St. Rank hold LXRX as of Q3 2025.

  • Quintet Private Bank (Europe) reported no remaining Lexicon Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Quintet Private Bank (Europe) sold 1,928 Lexicon Pharmaceuticals shares in Q3 2025, an estimated $1.82K.
  • Quintet Private Bank (Europe) first reported a position in Lexicon Pharmaceuticals in Q2 2022 and held it in 11 quarters.
  • Quintet Private Bank (Europe)'s Lexicon Pharmaceuticals position peaked at $4.69K in Q1 2023.
  • 123 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q3 2025.

Based on Quintet Private Bank (Europe)'s 13F filing for Q3 2025, filed 7 Oct 2025.